4/11
09:19 am
ophly
XCOPRI® (cenobamate tablets) CV Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube [Yahoo! Finance]
Low
Report
XCOPRI® (cenobamate tablets) CV Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube [Yahoo! Finance]
4/9
10:07 am
ophly
SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
Low
Report
SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
3/21
07:06 am
ophly
ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL [Yahoo! Finance]
Low
Report
ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL [Yahoo! Finance]
3/14
04:18 am
ophly
Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System Disorders [Yahoo! Finance]
Low
Report
Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System Disorders [Yahoo! Finance]
3/11
08:16 am
ophly
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University [Yahoo! Finance]
Low
Report
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University [Yahoo! Finance]
2/20
11:00 pm
ophly
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets [Yahoo! Finance]
Low
Report
Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets [Yahoo! Finance]
2/19
02:13 am
ophly
InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery [Yahoo! Finance]
Low
Report
InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery [Yahoo! Finance]
2/14
03:11 am
ophly
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer [Yahoo! Finance]
Low
Report
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer [Yahoo! Finance]